2.55 USD
+0.05 (+2.00%)
AT CLOSE (11:59 AM EDT)
Cellectar Biosciences INC NEW (CLRB)
NASDAQ: CLRB • USD
2.47
-0.00 (-0.04%)
POST MARKET (AS OF 05:43 PM EDT)
Market: OPEN
Open?$2.45
High?$2.63
Low?$2.44
Prev. Close?$2.50
Volume?30.7K
Avg. Volume?47.2K
VWAP?$2.53
Rel. Volume?0.65x
Bid / Ask
Bid?$2.13 × 100
Ask?$2.98 × 100
Spread?$0.85
Midpoint?$2.55
Valuation & Ratios
Market Cap?10.6M
Shares Out?4.2M
Float?2.9M
Float %?92.2%
P/E Ratio?N/A
P/B Ratio?1.24
EPS?-$5.14
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.96Strong
Quick Ratio?2.96Strong
Cash Ratio?2.78Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?1.24CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-255.3%WEAK▾
ROA?-145.5%WEAK▾
Cash Flow & Enterprise
FCF?$-23124097
Enterprise Value?$-2595711
Related Companies
Loading...
News
Profile
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Employees
11
Market Cap
10.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2005-04-19
Address
100 CAMPUS DRIVE
FLORHAM PARK, NJ 07932
Phone: (608) 441-8120
FLORHAM PARK, NJ 07932
Phone: (608) 441-8120